Free UC Blue Ash presentation focuses on communicating with patients with autism disorders
The free presentation will be held in Muntz Hall on the UC Blue Ash campus from 12:30 - 2 p.m. on Feb. 21
The University of Cincinnati Blue Ash College will host a free presentation designed to help health care providers communicate effectively with patients with autism spectrum disorders (ASDs).
The event will be held from 12:30 - 2 p.m. on Thursday, Feb. 21, in Muntz Hall, Room 170, on the UC Blue Ash College campus. It is sponsored by the UC Blue Ash Allied Health Department Diversity Awareness Committee.
Jerry Tyree, program director for the Columbus State Community College School of Radiologic Technology, will lead the presentation "Communicating with Patients with Autism Spectrum Disorders." Tyree brings a personal knowledge of individuals with ASDs through his experience of raising his son.
According to the Centers for Disease Control (CDC), ASDs are a group of developmental disabilities that can cause significant social, communication and behavioral challenges. They affect each person in different ways, and can range from mild to severe.
The purpose of the presentation will be help participants understand ASDs, identify the challenges or difficulties a hospital environment could create, and know the importance of how to ask questions and gather information from a patient with an ASD.
If you need more information about the event, you can contact the Allied Health Department at UC Blue Ash at (513) 936-1631.
Tags
Related Stories
UC Law blog is a window into scholarship, teaching, and practice
March 13, 2026
UC Law launches new blog to highlight thought leadership pieces of faculty, staff, alumni and others.
Student Lighting Designer named 2026 Howell Binkley Fellow
March 10, 2026
University of Cincinnati College-Conservatory of Music student Jules Cabrera, MFA Lighting Design and Technology, is the 2026 Howell Binkley Fellow, presented by Hemsley Lighting Programs.
Study: Additional radiation for liver cancer does not increase toxicity
March 10, 2026
New research led by University of Cincinnati Cancer Center researchers published in the American Journal of Clinical Oncology found external beam radiation therapy (EBRT) is safe to administer to patients with liver cancer even after they undergo a targeted internal radiation therapy called Y90.